UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
Simulations Plus
SLP
$371M
| $495K | ﹤0.01% |
10,175
-6,657
| -40% | -$314K |
|
5002
State Street SPDR S&P Health Care Services ETF
XHS
$208M
| $494K | ﹤0.01% |
5,491
-146
| -3% | -$13.2K |
|
5003
Schrodinger
SDGR
$1.36B
| $492K | ﹤0.01% |
25,430
-45,690
| -64% | -$1.05M |
|
|
KEEL
5004
Keel Infrastructure Corp
KEEL
$2.34B
| $492K | ﹤0.01% |
191,315
+161,230
| +536% | +$347K |
|
|
ACCD
5005
DELISTED
Accolade Inc
ACCD
| $491K | ﹤0.01% |
137,111
+23,968
| +21% | +$182K |
|
|
FITE
5006
State Street SPDR S&P Kensho Future Security ETF
FITE
$155M
| $491K | ﹤0.01% |
8,670
+136
| +2% | +$7.54K |
|
5007
Xenon Pharmaceuticals
XENE
$6.12B
| $490K | ﹤0.01% |
12,578
-23,668
| -65% | -$946K |
|
5008
Univest Financial
UVSP
$1.18B
| $490K | ﹤0.01% |
21,481
-17,495
| -45% | -$370K |
|
5009
West Bancorporation
WTBA
$485M
| $488K | ﹤0.01% |
27,285
-12,715
| -32% | -$216K |
|
|
EXK
5010
Endeavour Silver
EXK
$2.83B
| $487K | ﹤0.01% |
138,489
+117,006
| +545% | +$380K |
|
|
DESP
5011
DELISTED
Despegar.com
DESP
| $487K | ﹤0.01% |
36,794
+34,348
| +1,404% | +$452K |
|
5012
Vanguard US Multifactor ETF
VFMF
$920M
| $484K | ﹤0.01% |
3,952
+172
| +5% | +$21.1K |
|
5013
WisdomTree Emerging Markets Local Debt Fund
ELD
$143M
| $483K | ﹤0.01% |
18,324
+1,660
| +10% | +$44.6K |
|
5014
ODDITY Tech
ODD
$651M
| $483K | ﹤0.01% |
12,291
-3,682
| -23% | -$137K |
|
5015
Nabors Industries
NBR
$1.21B
| $481K | ﹤0.01% |
6,755
-224
| -3% | -$16.7K |
|
5016
Accuray
ARAY
$34M
| $480K | ﹤0.01% |
263,965
+21,140
| +9% | +$40.3K |
|
5017
Stem
STEM
$52.7M
| $480K | ﹤0.01% |
21,616
-19,143
| -47% | -$561K |
|
5018
Alector
ALEC
$199M
| $480K | ﹤0.01% |
105,685
-123,801
| -54% | -$637K |
|
5019
BlueLinx
BXC
$706M
| $480K | ﹤0.01% |
5,151
-5,627
| -52% | -$597K |
|
5020
Star Group
SGU
$423M
| $479K | ﹤0.01% |
45,031
-8,373
| -16% | -$90.1K |
|
5021
JPMorgan High Yield Municipal ETF
JMHI
$293M
| $479K | ﹤0.01% |
9,618
-13,957
| -59% | -$690K |
|
5022
CALL
AGNC Investment
AGNC
$12.9B
| $477K | ﹤0.01% |
50,000
-250,000
| -83% | -$2.39M |
|
5023
Marcus & Millichap
MMI
$1.19B
| $477K | ﹤0.01% |
15,118
-14,169
| -48% | -$459K |
|
5024
GoPro
GPRO
$126M
| $474K | ﹤0.01% |
334,027
-94,042
| -22% | -$157K |
|
|
JNPR
5025
PUT
DELISTED
Juniper Networks
JNPR
| $474K | ﹤0.01% |
13,000
-23,700
| -65% | -$842K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.